Filing Details
- Accession Number:
- 0001209191-22-023224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-05 17:42:43
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-05 17:42:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 831547 | Spectrum Pharmaceuticals Inc | SPPI | Pharmaceutical Preparations (2834) | 930979187 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1038704 | Francois Lebel | 11500 S. Eastern Ave., Suite 220 Henderson NV 89052 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2022-04-04 | 1,205 | $1.35 | 253,880 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2022-04-05 | 1,367 | $1.41 | 252,513 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.001 Par Value | 7,226 | Indirect | By 401(k) plan |
Footnotes
- All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
Billionaire Hedge Funds
